Go Symbol Lookup
Loading...

HSBC Drags Europe to Weak Close

Stocks to Watch: JOE, BAH, TEA & More

 Text Size  
Published: Wednesday, 30 May 2012 | 1:47 PM ET

Take a look at some of Wednesday's midday movers:

Forest Labs is holding its own on a down market day. Billionaire investor Carl Icahn plans to nominate another slate of directors to company's board. Icahn holds a 9.92 percent stake in the drugmaker.

St Joe fell after Greenlight Capital’s David Einhorn criticized the Florida developer again, saying the business model is flawed and the company still needs to take further write-downs on its unsold beachfront real estate.

Booz Allen Hamilton rose after the consulting firm reported a stronger-than-expected quarterly profit on growth at its defense, civil and intelligence businesses.

Steel stocks, including AK Steel ,U.S. Steel ,Nucor , and SteelDynamics fell as the euro continued to weaken.

Oil and oil services stocks slid as oil fell below the $90 a barrel. Exxon Mobil ,Chevron ,BP ,Halliburton , and Schlumberger were all lower.

Darden Restaurants skidded after BofA Merrill removed the restaurant company from its US 1 list.

Specialty tea retailer Teavana Holdings plunged after the company reported lower-than-expected quarterly revenue on tepid sales at its stores open at least a year.

Monsanto moved higher after the global agricultural company raised its fiscal guidance for 2012, and said strong growth would continue in 2013.

Macy’s lower despite reporting better than expected May same store sales, helped by its growing e-commerce business. Other department stores, including Sears ,Kohl’s , and JC Penney also weakened.

Homebuilders moved lower after a report showed pending home prices unexpectedly fell 5.5 percentin April to a four month low. Lennar ,DRHorton ,KB Homes , and Pulte all to the downside.

Coal stocks among the commodities that fell. Peabody Energy ,Walter Energy ,Consol Energy , Alpha Natural , and Arch Coal all lower.

Human Genome Sciences lower on a Reuters report that GlaxoSmithKline will likely begin a campaign to replace the entire Human Genome board. This as its steps up its $2.6 billion hostile bid for the biotech company.

Questions? Comments? Email us at marketinsider@cnbc.com

 Print
Take a look at some of Wednesday's midday movers:
  Price   Change %Change
ACI ---
AKS ---
ANR ---
BAH ---
BP. ---
BTU ---
CNX ---
CVX ---
DHI ---
DRI ---
FRX ---
GSK ---
HAL ---
HGSI ---
JCP ---
JOE ---
KBH ---
KSS ---
LEN ---
M ---
MO ---
NUE ---
PHM ---
SHLD ---
SLB ---
STLD ---
WLT ---
X ---
XOM ---
TV1 ---

   
Comments

 

More Comments

 
 

Add Comments

 

Your Comments (Up to 1100 characters):

Remaining characters

Your comments have not been posted yet.

Please review your submission to make sure you are comfortable with your entry.

Your Comments:


                
            
            
        

Featured

  • Patti Domm is CNBC Executive Editor, News, responsible for news coverage of the markets and economy.

  • Greenberg is senior stocks commentator for CNBC appearing throughout business day programming and on CNBC.com.

  • A CNBC reporter since 1990, Pisani reports on Wall Street and the stock market from the floor of the New York Stock Exchange. Follow him on Twitter @BobPisani.

  • Epperson covers the global energy, metals and commodities markets from the NY Mercantile Exchange for CNBC and CNBC.com.

  • Santelli joined CNBC Business News as an on-air editor in 1999, reporting live from the floor of the Chicago Board of Trade.

  • Senior Editor at CNBC, commodity trader in a former life.

  • CNBC Markets Producer

  • Senior Producer at CNBC's Breaking News Desk.

  • Website Producer at CNBC